Key facts
- This page summarizes Thomas Pfisterer's Form 3 filing for ADC Therapeutics SA (ADCT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jan 2024, 20:00.
Thomas Pfisterer - 02 Jan 2024 Form 3 Insider Report for ADC Therapeutics SA (ADCT)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- ADCT
- Reported as of
- 02 Jan 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 02 Jan 2024, 20:00:16 UTC
- Next SEC filing
- 14 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ameet Mallik, as Attorney-in-Fact for Thomas Pfisterer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas Pfisterer filed Form 3 for ADC Therapeutics SA (ADCT) on 02 Jan 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADCT
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 175,337
- Date
- 02 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
ADCT
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 451,856
- Date
- 02 Jan 2024
- Ownership
- By HPWH TH AG
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 20,000 Common Shares to be delivered in settlement of a restricted share unit award ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Shares. The RSUs were granted on June 14, 2023 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.
Footnote F2
The reporting person disclaims beneficial ownership of all Common Shares held of record by HPWH TH AG ("HPWH"), other than the Common Shares in HPWH that are indirectly represented by the reporting person's 41.7% interest in HPWH MH AG, which owns a 12.5% interest in HPWH, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the remaining Common Shares in HPWH for purposes of Section 16 or for any other purpose.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney